TLIS - Talis Biomedical EPS beats by $0.18 beats on revenue November, 15 2021 04:14 PM Talis Biomedical Corporation Talis Biomedical (NASDAQ:TLIS): GAAP EPS of -$1.49 beats by $0.18. Revenue of $218M (+2219.1% Y/Y) beats by $216.54M. Press Release For further details see: Talis Biomedical EPS beats by $0.18, beats on revenue